These are the sources and citations used to research BioRNA quantest poly and ref. This bibliography was generated on Cite This For Me on
In-text: (Asif, 2014)
Your Bibliography: Asif, M., 2014. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. Journal of Education and Health Promotion, 3(1), p.1.
In-text: (Eriksson et al., 2002)
Your Bibliography: Eriksson, J., Lindi, V., Uusitupa, M., Forsen, T., Laakso, M., Osmond, C. and Barker, D., 2002. The Effects of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor- 2 Gene on Insulin Sensitivity and Insulin Metabolism Interact With Size at Birth. Diabetes, 51(7), pp.2321-2324.
In-text: (F. Hurley, 2006)
Your Bibliography: F. Hurley, B., 2006. ADRENERGIC RECEPTOR(ADR) GENOTYPE INFLUENCES THE EFFECTS OF STRENGTH TRAINING ON MID-THIGH INTERMUSCULAR FAT. [online] Pdfs.semanticscholar.org. Available at: <https://pdfs.semanticscholar.org/f0e2/143b25a600f428e68854389fc01aab67f730.pdf> [Accessed 26 June 2018].
In-text: (Grayson, 2013)
Your Bibliography: Grayson, C., 2013. [online] Urbanstrengthinstitute.com. Available at: <http://urbanstrengthinstitute.com/wp-content/uploads/2013/12/Grayson-Genetic-Test.pdf> [Accessed 26 June 2018].
In-text: (Hu et al., 2012)
Your Bibliography: Hu, T., Mills, K., Yao, L., Demanelis, K., Eloustaz, M., Yancy, W., Kelly, T., He, J. and Bazzano, L., 2012. Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials. American Journal of Epidemiology, 176(suppl_7), pp.S44-S54.
In-text: (Leite et al., 2018)
Your Bibliography: Leite, N., Silva, L., Jesus, Í., Lopes, W., Cavaglieri, C., Consentino, C., Radominski, R., Souza, R., Tureck, L. and Furtado-Alle, L., 2018. ADRB2 Gln27Glu polymorphism influenced changes in leptin but not body composition or metabolic and other inflammatory parameters after twelve weeks of combined training in overweight adolescents. Motriz: Revista de Educação Física, 23(spe2).
In-text: (Macho-Azcarate et al., 2018)
Your Bibliography: Macho-Azcarate, T., Marti, A., Gonza´lez, A., Martinez, J. and Iban˜ez, J., 2018. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. [online] Dadun.unav.edu. Available at: <https://dadun.unav.edu/bitstream/10171/17844/3/IntJObes200226%2811%29.pdf> [Accessed 26 June 2018].
In-text: (Maciejewska-Karlowska et al., 2013)
Your Bibliography: Maciejewska-Karlowska, A., Sawczuk, M., Cieszczyk, P., Zarebska, A. and Sawczyn, S., 2013. Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status. PLoS ONE, 8(6), p.e67172.
In-text: (Monsalve, Pyarasani, Delgado-Lopez and Moore-Carrasco, 2013)
Your Bibliography: Monsalve, F., Pyarasani, R., Delgado-Lopez, F. and Moore-Carrasco, R., 2013. Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases. Mediators of Inflammation, 2013, pp.1-18.
In-text: (Phares et al., 2004)
Your Bibliography: Phares, D., Halverstadt, A., Shuldiner, A., Ferrell, R., Douglass, L., Ryan, A., Goldberg, A. and Hagberg, J., 2004. Association Between Body Fat Response to Exercise Training and MultilocusADRGenotypes. Obesity Research, 12(5), pp.807-815.
In-text: (Shiwaku et al., 2003)
Your Bibliography: Shiwaku, K., Nogi, A., Anuurad, E., Kitajima, K., Enkhmaa, B., Shimono, K. and Yamane, Y., 2003. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene. International Journal of Obesity, 27(9), pp.1028-1036.
In-text: (Simoes et al., 2017)
Your Bibliography: Simoes, R., Freitas, J., Barbosa, A., Mascarenhas, M. and Bicho, M., 2017. Beta-2 adrenergic receptor (ADRB2) gene polymorphism Arg16Gly as risk factor for osteoporosis. Endocrine Abstracts,.
In-text: (Temelkova-Kurktschiev et al., 2004)
Your Bibliography: Temelkova-Kurktschiev, T., Hanefeld, M., Chinetti, G., Zawadzki, C., Haulon, S., Kubaszek, A., Koehler, C., Leonhardt, W., Staels, B. and Laakso, M., 2004. Ala12Ala Genotype of the Peroxisome Proliferator-Activated Receptor γ2 Protects against Atherosclerosis. The Journal of Clinical Endocrinology & Metabolism, 89(9), pp.4238-4242.
In-text: (Tyagi et al., 2011)
Your Bibliography: Tyagi, S., Sharma, S., Gupta, P., Saini, A. and Kaushal, C., 2011. The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. Journal of Advanced Pharmaceutical Technology & Research, 2(4), p.236.
In-text: (Vardeny et al., 2012)
Your Bibliography: Vardeny, O., Nicholas, G., Andrei, A., Buhr, K., Hermanson, M., Moran, J., Detry, M. and Stein, J., 2012. β-AR Polymorphisms and Glycemic and Lipid Parameters in Hypertensive Individuals Receiving Carvedilol or Metoprolol. American Journal of Hypertension, 25(8), pp.920-926.
In-text: (Yates et al., 2015)
Your Bibliography: Yates, T., Davies, M., Henson, J., Edwardson, C., Webb, D., Bodicoat, D., Webb, M., Howard, P., Cooper, J., Humphries, S., Khunti, K. and Talmud, P., 2015. Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes. PLOS ONE, 10(5), p.e0124062.
10,587 students joined last month!